Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2005 1
2006 1
2009 1
2011 2
2012 2
2013 1
2014 2
2015 2
2018 1
2019 4
2020 6
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury: The COBI Randomized Clinical Trial.
Roquilly A, Moyer JD, Huet O, Lasocki S, Cohen B, Dahyot-Fizelier C, Chalard K, Seguin P, Jeantrelle C, Vermeersch V, Gaillard T, Cinotti R, Demeure Dit Latte D, Mahe PJ, Vourc'h M, Martin FP, Chopin A, Lerebourg C, Flet L, Chiffoleau A, Feuillet F, Asehnoune K; Atlanrea Study Group and the Société Française d’Anesthésie Réanimation (SFAR) Research Network. Roquilly A, et al. Among authors: chiffoleau a. JAMA. 2021 May 25;325(20):2056-2066. doi: 10.1001/jama.2021.5561. JAMA. 2021. PMID: 34032829 Free PMC article. Clinical Trial.
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.
Grégoire M, Dailly E, Le Turnier P, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Lemaitre F, Verdier MC, Deslandes G, Bellouard R, Sébille V, Chiffoleau A, Boutoille D, Navas D, Asseray N. Grégoire M, et al. Among authors: chiffoleau a. Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00634-19. doi: 10.1128/AAC.00634-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31235630 Free PMC article. Clinical Trial.
Public Health Impact of Using Biosimilars, Is Automated Follow up Relevant?
Perpoil A, Grimandi G, Birklé S, Simonet JF, Chiffoleau A, Bocquet F. Perpoil A, et al. Among authors: chiffoleau a. Int J Environ Res Public Health. 2020 Dec 29;18(1):186. doi: 10.3390/ijerph18010186. Int J Environ Res Public Health. 2020. PMID: 33383867 Free PMC article. Review.
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F; POLYCOR study group. Gaborit B, et al. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad525. doi: 10.1093/ofid/ofad525. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 37942459 Free PMC article.
[Hypersensitivity to celecoxib].
Fradet G, Robin-Le Nechet A, Huguenin H, Chiffoleau A. Fradet G, et al. Among authors: chiffoleau a. Ann Med Interne (Paris). 2003 May;154(3):181-2. Ann Med Interne (Paris). 2003. PMID: 12910047 French.
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study.
Le Turnier P, Navas D, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Chiffoleau A, Dary M, Leclair-Visonneau L, Grégoire M, Pere M, Boutoille D, Sébille V, Dailly E, Asseray N; High-Dose Ceftriaxone CNS Infections Study Group. Le Turnier P, et al. Among authors: chiffoleau a. J Antimicrob Chemother. 2019 Apr 1;74(4):1078-1085. doi: 10.1093/jac/dky553. J Antimicrob Chemother. 2019. PMID: 30698733 Clinical Trial.
[Grapefruit consumption and food-drug interaction hazard].
Roulet L, Asseray N, Mottier ML, Chiffoleau A, Potel G, Lapeyre-Mestre M, Ballereau F. Roulet L, et al. Among authors: chiffoleau a. Therapie. 2011 Sep-Oct;66(5):421-9. doi: 10.2515/therapie/2011051. Epub 2011 Oct 27. Therapie. 2011. PMID: 22031686 French.
PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy.
Le Gouill-Jaijarat C, Péréon Y, Leroy M, Lépine O, Loloum A, Peluchon C, Volteau C, Martineau AS, Korner S, Perrault C, Benmaziane A, Girot P, Petorin C, Perret C, Ligeza-Poisson C, Mayeur D, Flet L, Chiffoleau A, Poinas A, Bennouna J. Le Gouill-Jaijarat C, et al. Among authors: chiffoleau a. Trials. 2023 Jan 20;24(1):50. doi: 10.1186/s13063-023-07071-z. Trials. 2023. PMID: 36670495 Free PMC article.
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
Gaborit B, Dailly E, Vanhove B, Josien R, Lacombe K, Dubee V, Ferre V, Brouard S, Ader F, Vibet MA, Le Thuaut A, Danger R, Flet L, Omnes A, Berly L, Chiffoleau A, Jobert A, Duvaux O, Raffi F; POLYCOR Trial Group. Gaborit B, et al. Among authors: chiffoleau a. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0123721. doi: 10.1128/AAC.01237-21. Epub 2021 Aug 17. Antimicrob Agents Chemother. 2021. PMID: 34181475 Free PMC article. Clinical Trial.
FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
Poinas A, Lemoigne M, Le Naour S, Nguyen JM, Schirr-Bonnans S, Riche VP, Vrignaud F, Machet L, Claudel JP, Leccia MT, Hainaut E, Beneton N, Dert C, Boisrobert A, Flet L, Chiffoleau A, Corvec S, Khammari A, Dréno B. Poinas A, et al. Among authors: chiffoleau a. Trials. 2020 Jun 25;21(1):571. doi: 10.1186/s13063-020-04432-w. Trials. 2020. PMID: 32586344 Free PMC article.
29 results